High density lipoprotein subfractions in non-insulin-dependent diabetes mellitus and coronary artery disease.

High density lipoprotein (HDL) subfractions (2b, 2a, 3a, 3b, and 3c) separated by gradient gel electrophoresis (GGE) and defined by Gaussian summation analysis, and the compositions of HDL2 and HDL3, separated by preparative ultracentrifugation, were studied in four groups of men with or without non-insulin-dependent diabetes mellitus (NIDDM) and coronary artery disease (CAD): group 1 (DM+CAD+, n = 50); group 2 (DM-CAD+, n = 50); group 3 (DM+CAD-, n = 50); and group 4 (DM-CAD-, n = 31). HDL GGE subfraction distributions, available in 125 subjects, were not significantly different among the groups. In contrast, dividing the whole study population into quartiles of serum triglyceride (TG) concentration showed that high TG levels were significantly associated with low HDL2b and high HDL3b concentrations. In a multivariate linear regression model, postheparin plasma hepatic lipase (HL) activity, and fasting serum insulin and TG concentrations were all associated independently and inversely with low HDL2b, but lipoprotein lipase or cholesteryl ester transfer protein activities were not correlated with HDL2b concentrations. Group 1 tended to have the smallest mean particle sizes in the HDL subfractions, significantly (P < 0.03, CAD vs. non-CAD) for HDL2b and for HDL2a. These differences were independent of TG, insulin and HL, but lost their significance when adjusted for beta-blocker therapy. Both HDL2 and HDL3 particles in group 1 were significantly depleted of unesterified cholesterol, and their HDL2 was TG-enriched (P = 0.053). A high HL activity, hyperinsulinemia and hypertriglyceridemia are independently associated with low levels of HDL2b and generally small HDL particle size. HDL particles in subjects with NIDDM and CAD are small-sized and have a low free cholesterol content. Both these characteristics may be markers of impaired reverse cholesterol transport.

[1]  P. MacLean,et al.  Lipoprotein metabolism in non-insulin-dependent diabetes mellitus , 1996 .

[2]  H. Wilson,et al.  Alterations in the concentration of an apolipoprotein E-containing subfraction of plasma high density lipoprotein in coronary heart disease. , 1993, Clinica chimica acta; international journal of clinical chemistry.

[3]  M. Laakso,et al.  Lipids and Lipoproteins Predicting Coronary Heart Disease Mortality and Morbidity in Patients With Non-insulin-dependent Diabetes , 1993 .

[4]  G. Ponsin,et al.  Decreased ability of high density lipoproteins to transfer cholesterol esters in non‐insulin‐dependent diabetes mellitus , 1993, European journal of clinical investigation.

[5]  M. Taskinen,et al.  Gemfibrozil reduces postprandial lipemia in non-insulin-dependent diabetes mellitus. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[6]  R. Krauss,et al.  Reduced HDL2 cholesterol subspecies and elevated postheparin hepatic lipase activity in older men with abdominal obesity and asymptomatic myocardial ischemia. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[7]  Y. Marcel,et al.  Reduction in the concentration and activity of plasma cholesteryl ester transfer protein by alcohol. , 1992, Journal of lipid research.

[8]  B. G. Brown,et al.  Altered particle size distribution of apolipoprotein A-I-containing lipoproteins in subjects with coronary artery disease. , 1991, Journal of lipid research.

[9]  A. Hamsten,et al.  The association of lipoprotein and hepatic lipase activities with high density lipoprotein subclass levels in men with myocardial infarction at a young age. , 1991, Atherosclerosis.

[10]  M. Taskinen 3 Hyperlipidaemia in diabetes , 1990 .

[11]  M. King,et al.  Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. , 1990, Circulation.

[12]  D. Gordon,et al.  High-density lipoprotein--the clinical implications of recent studies. , 1989, The New England journal of medicine.

[13]  C. Bouchard,et al.  Role of hepatic-triglyceride lipase activity in the association between intra-abdominal fat and plasma HDL cholesterol in obese women. , 1989, Arteriosclerosis.

[14]  A. Goldberg,et al.  Measurement of normative HDL subfraction cholesterol levels by Gaussian summation analysis of gradient gels. , 1989, Journal of lipid research.

[15]  R. Eckel,et al.  Lipoprotein lipase. A multifunctional enzyme relevant to common metabolic diseases. , 1989, The New England journal of medicine.

[16]  M. Taskinen,et al.  Insulin Therapy Induces Antiatherogenic Changes of Serum Lipoproteins in Noninsulin‐Dependent Diabetes , 1988, Arteriosclerosis.

[17]  R. Maughan,et al.  Plasma high density lipoprotein subfractions in subjects with different coronary risk indices as assessed by plasma lipoprotein concentrations. , 1988, Atherosclerosis.

[18]  M. Taskinen,et al.  7 Enzymes involved in triglyceride hydrolysis , 1987 .

[19]  H. Ginsberg Very low density lipoprotein metabolism in diabetes mellitus. , 1987, Diabetes/metabolism reviews.

[20]  M. Taskinen Lipoprotein lipase in diabetes. , 1987, Diabetes/metabolism reviews.

[21]  M. Laakso,et al.  Diabetes and atherosclerosis: an epidemiologic view. , 1987, Diabetes/metabolism reviews.

[22]  G. Reaven Non-insulin-dependent diabetes mellitus, abnormal lipoprotein metabolism, and atherosclerosis. , 1987, Metabolism: clinical and experimental.

[23]  N. Miller,et al.  The anatomy and physiology of reverse cholesterol transport. , 1986, Clinical science.

[24]  J. Groener,et al.  Improved estimation of cholesteryl ester transfer/exchange activity in serum or plasma. , 1986, Clinical chemistry.

[25]  P. Barter,et al.  Particle size distribution of high density lipoproteins as a function of plasma triglyceride concentration in human subjects. , 1985, Atherosclerosis.

[26]  A. Gotto,et al.  Postprandial lipemia. A key for the conversion of high density lipoprotein2 into high density lipoprotein3 by hepatic lipase. , 1984, The Journal of clinical investigation.

[27]  S. Eisenberg,et al.  High density lipoprotein metabolism. , 1984, Journal of lipid research.

[28]  S. Eisenberg,et al.  Plasma triglyceride determines structure-composition in low and high density lipoproteins. , 1984, Arteriosclerosis.

[29]  E. Gong,et al.  Characterization of human high-density lipoproteins by gradient gel electrophoresis. , 1981, Biochimica et biophysica acta.

[30]  M. Kashyap,et al.  A rapid and simple method for measurement of total protein in very low density lipoproteins by the Lowry assay. , 1980, Journal of lipid research.

[31]  F. Lindgren,et al.  High density lipoprotein distribution. Resolution and determination of three major components in a normal population sample. , 1978, Atherosclerosis.

[32]  N. Miller,et al.  THE TROMSØHEART-STUDY HIGH-DENSITY LIPOPROTEIN AND CORONARY HEART-DISEASE: A PROSPECTIVE CASE-CONTROL STUDY , 1977, The Lancet.

[33]  M C Hjortland,et al.  High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. , 1977, The American journal of medicine.

[34]  A Kagan,et al.  Serum lipoproteins and coronary heart disease in a population study of Hawaii Japanese men. , 1976, The New England journal of medicine.

[35]  P. Kinnunen,et al.  An immunochemical method for the selective measurement of two triglyceride lipases in human postheparin plasma. , 1975, Clinica chimica acta; international journal of clinical chemistry.

[36]  S. Grundy,et al.  Two different views of the relationship of hypertriglyceridemia to coronary heart disease. Implications for treatment. , 1992, Archives of internal medicine.

[37]  E. Bierman Atherogenesis in diabetes , 1992 .

[38]  P. Subbaiah,et al.  Lipoprotein composition and HDL particle size distribution in women with non-insulin-dependent diabetes mellitus and the effects of probucol treatment. , 1991, The Journal of laboratory and clinical medicine.

[39]  A. Hamsten,et al.  High density lipoproteins and coronary atherosclerosis. A strong inverse relation with the largest particles is confined to normotriglyceridemic patients. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[40]  D. Gordon,et al.  High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. , 1989, Circulation.

[41]  M. Taskinen,et al.  Enzymes involved in triglyceride hydrolysis. , 1987, Bailliere's clinical endocrinology and metabolism.

[42]  R. Krauss,et al.  Nondenaturing polyacrylamide gradient gel electrophoresis. , 1986, Methods in enzymology.